Macejak D - Search Results

1

Macejak D. Macejak D. Science. 2020 Sep 18;369(6510):1534. doi: 10.1126/science.369.6510.1534. Science. 2020. PMID: 32943528 No abstract available.

2

Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection.

Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T. Neu U, et al. Among authors: macejak d. PLoS Pathog. 2012;8(7):e1002738. doi: 10.1371/journal.ppat.1002738. Epub 2012 Jul 26. PLoS Pathog. 2012. PMID: 22910713 Free PMC article.

3

Structures of the major capsid proteins of the human Karolinska Institutet and Washington University polyomaviruses.

Neu U, Wang J, Macejak D, Garcea RL, Stehle T. Neu U, et al. Among authors: macejak d. J Virol. 2011 Jul;85(14):7384-92. doi: 10.1128/JVI.00382-11. Epub 2011 May 4. J Virol. 2011. PMID: 21543504 Free PMC article.

4

Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR.

McLoughlin K, Turteltaub K, Bankaitis-Davis D, Gerren R, Siconolfi L, Storm K, Cheronis J, Trollinger D, Macejak D, Tryon V, Bevilacqua M. McLoughlin K, et al. Among authors: macejak d. Mol Med. 2006 Jul-Aug;12(7-8):185-95. doi: 10.2119/2006-00018.McLoughlin. Mol Med. 2006. PMID: 17088951 Free PMC article. Clinical Trial.

5

Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.

Malerczyk C, Schulte AM, Czubayko F, Bellon L, Macejak D, Riegel AT, Wellstein A. Malerczyk C, et al. Among authors: macejak d. Gene Ther. 2005 Feb;12(4):339-46. doi: 10.1038/sj.gt.3302398. Gene Ther. 2005. PMID: 15496960

6

Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.

Morrissey DV, Lee PA, Johnson DA, Overly SL, McSwiggen JA, Beigelman L, Mokler VR, Maloney L, Vargeese C, Bowman K, O'Brien JT, Shaffer CS, Conrad A, Schmid P, Morrey JD, Macejak DG, Pavco PA, Blatt LM. Morrissey DV, et al. Among authors: macejak dg. J Viral Hepat. 2002 Nov;9(6):411-8. doi: 10.1046/j.1365-2893.2002.00383.x. J Viral Hepat. 2002. PMID: 12431202

7

Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA.

Macejak DG, Jensen KL, Pavco PA, Phipps KM, Heinz BA, Colacino JM, Blatt LM. Macejak DG, et al. J Viral Hepat. 2001 Nov;8(6):400-5. doi: 10.1046/j.1365-2893.2001.00321.x. J Viral Hepat. 2001. PMID: 11703570

8

Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.

Macejak DG, Jensen KL, Jamison SF, Domenico K, Roberts EC, Chaudhary N, von Carlowitz I, Bellon L, Tong MJ, Conrad A, Pavco PA, Blatt LM. Macejak DG, et al. Hepatology. 2000 Mar;31(3):769-76. doi: 10.1002/hep.510310331. Hepatology. 2000. PMID: 10706571

9

Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.

Macejak DG, Lin H, Webb S, Chase J, Jensen K, Jarvis TC, Leiden JM, Couture L. Macejak DG, et al. J Virol. 1999 Sep;73(9):7745-51. doi: 10.1128/JVI.73.9.7745-7751.1999. J Virol. 1999. PMID: 10438864 Free PMC article.

10

Ribozymes in gene therapy.

Thompson JD, Macejak D, Couture L, Stinchcomb DT. Thompson JD, et al. Among authors: macejak d. Nat Med. 1995 Mar;1(3):277-8. doi: 10.1038/nm0395-277. Nat Med. 1995. PMID: 7585047 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters